Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhexing Wen

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Molecular Psychiatry|March 10, 2022
Schizophrenia: a disorder of broken brain bioenergeticsNicholas D Henkel, Xiajoun Wu, Sinead M O'Donovan, et al.
Cell Reports|April 28, 2021
5-hydroxymethylcytosine is dynamically regulated during forebrain organoid development and aberrantly altered in Alzheimer's diseaseJanise N Kuehner, Junyu Chen, Emily C Bruggeman, et al.
Nature Neuroscience|April 17, 2019
A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS dataQuan Wang, Rui Chen, Feixiong Cheng, et al.
Nature Communications|January 8, 2026
Integrative transcriptome-wide association analyses reveal PRKCG-linked GABAergic dysfunction in Fragile X-associated tremor/ataxia syndromeYulin Jin, Yiqu Cao, Wenjing Ma, et al.
Molecular Psychiatry|August 25, 2019
Structural interaction between DISC1 and ATF4 underlying transcriptional and synaptic dysregulation in an iPSC model of mental disordersXinyuan Wang, Fei Ye, Zhexing Wen, et al.
NPJ Digital Medicine|February 27, 2024
Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validationChao Yan, Monika E Grabowska, Alyson L Dickson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer's Disease in Real-World Clinical DatasetsChao Yan, Monika E Grabowska, Alyson L Dickson, et al.
Molecular Psychiatry|August 6, 2020
TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment responseMing-Fen Ho, Cheng Zhang, Lingxin Zhang, et al.
Molecular Neurobiology|October 20, 2018
Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel TreatmentsCourtney R Sullivan, Catharine A Mielnik, Sinead M O'Donovan, et al.
Nature Communications|March 12, 2016
The TLX-miR-219 cascade regulates neural stem cell proliferation in neurodevelopment and schizophrenia iPSC modelKiyohito Murai, Guoqiang Sun, Peng Ye, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Molecular Psychiatry|March 10, 2022
Schizophrenia: a disorder of broken brain bioenergeticsNicholas D Henkel, Xiajoun Wu, Sinead M O'Donovan, et al.
Cell Reports|April 28, 2021
5-hydroxymethylcytosine is dynamically regulated during forebrain organoid development and aberrantly altered in Alzheimer's diseaseJanise N Kuehner, Junyu Chen, Emily C Bruggeman, et al.
Nature Neuroscience|April 17, 2019
A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS dataQuan Wang, Rui Chen, Feixiong Cheng, et al.
Nature Communications|January 8, 2026
Integrative transcriptome-wide association analyses reveal PRKCG-linked GABAergic dysfunction in Fragile X-associated tremor/ataxia syndromeYulin Jin, Yiqu Cao, Wenjing Ma, et al.
Molecular Psychiatry|August 25, 2019
Structural interaction between DISC1 and ATF4 underlying transcriptional and synaptic dysregulation in an iPSC model of mental disordersXinyuan Wang, Fei Ye, Zhexing Wen, et al.
NPJ Digital Medicine|February 27, 2024
Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validationChao Yan, Monika E Grabowska, Alyson L Dickson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer's Disease in Real-World Clinical DatasetsChao Yan, Monika E Grabowska, Alyson L Dickson, et al.
Molecular Psychiatry|August 6, 2020
TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment responseMing-Fen Ho, Cheng Zhang, Lingxin Zhang, et al.
Molecular Neurobiology|October 20, 2018
Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel TreatmentsCourtney R Sullivan, Catharine A Mielnik, Sinead M O'Donovan, et al.
Nature Communications|March 12, 2016
The TLX-miR-219 cascade regulates neural stem cell proliferation in neurodevelopment and schizophrenia iPSC modelKiyohito Murai, Guoqiang Sun, Peng Ye, et al.
Pageof 11